GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Total Stockholders Equity

Verseon (LSE:VERS) Total Stockholders Equity : £15.99 Mil (As of Jun. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Verseon Total Stockholders Equity?

Verseon's Total Stockholders Equity for the quarter that ended in Jun. 2019 was £15.99 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Verseon's Book Value per Share for the quarter that ended in Jun. 2019 was £0.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Verseon's Debt-to-Equity for the quarter that ended in Jun. 2019 was 1.36.


Verseon Total Stockholders Equity Historical Data

The historical data trend for Verseon's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Total Stockholders Equity Chart

Verseon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Stockholders Equity
Get a 7-Day Free Trial -8.35 53.53 49.05 30.96 16.96

Verseon Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.93 30.96 23.93 16.96 15.99

Verseon  (LSE:VERS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Verseon's Book Value per Share for the quarter that ended in Jun. 2019 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Verseon's Debt-to-Equity for the quarter that ended in Jun. 2019 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Verseon's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Verseon (LSE:VERS) Business Description

Industry
Traded in Other Exchanges
N/A
Address
47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.

Verseon (LSE:VERS) Headlines